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www.embomolmed.org EMSevere mental illnesses have been linked to white matter abnormalities, docu-
mented by postmortem studies. However, cause and effect have remained difficult
to distinguish. CNP (20,30-cyclic nucleotide 30-phosphodiesterase) is among the
oligodendrocyte/myelin-associated genes most robustly reduced on mRNA and
protein level in brains of schizophrenic, bipolar or major depressive patients. This
suggests that CNP reduction might be critical for a more general disease process
and not restricted to a single diagnostic category. We show here that reduced
expression of CNP is the primary cause of a distinct behavioural phenotype, seen
only upon aging as an additional ‘pro-inflammatory hit’. This phenotype is strik-
ingly similar in Cnp heterozygous mice and patients with mental disease carrying
the AA genotype at CNP SNP rs2070106. The characteristic features in both species
with their partial CNP ‘loss-of-function’ genotype are best described as ‘catatonia-
depression’ syndrome. As a consequence of perturbed CNP expression, mice show
secondary low-grade inflammation/neurodegeneration. Analogously, in man, dif-
fusion tensor imaging points to axonal loss in the frontal corpus callosum. To
conclude, subtle white matter abnormalities inducing neurodegenerative changes
can cause/amplify psychiatric diseases.INTRODUCTION
The CNP gene encodes the enzyme 20,30-cyclic nucleotide 30-
phosphodiesterase (CNP) which is present in non-compactedtute of Experimental
ute of Experimental
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BO Mol Med 4, 1–12myelin areas such as the inner mesaxon, paranodal loops and
Schmidt-Lantermann incisures (Braun et al, 2004; Yu et al,
1994), and accounts for about 4% of total central nervous
system myelin proteins (Braun et al, 2004). CNP is expressed
early in development of oligodendrocytes (Yu et al, 1994),
increases with onset of myelination and remains detectable in
these cells throughout life (Scherer et al, 1994). In vitro and
in vivo studies demonstrated a regulatory function of CNP for
process outgrowth in oligodendrocytes (Gravel et al, 1996; Lee
et al, 2005; Yin et al, 1997), as well as an interaction with
microtubules, cytoskeleton and RNA (Bifulco et al, 2002; De
Angelis & Braun, 1996; Gravel et al, 2009; Lee et al, 2005).
Studies employing homozygous Cnp-null mutant mice
revealed that Cnp is essential for axonal survival but not for
myelin assembly (Lappe-Siefke et al, 2003). In fact, Cnp/
mice show progressive axonal swellings and brain inflammation
with first motor deficits occurring at 4 months that progress to
severe hindlimb paralysis and death at 8–15 months (Lappe-
Siefke et al, 2003). In contrast, Cnpþ/ mice with a 50%
reduced Cnp expression do not exhibit any signs of inflamma- 2012 EMBO Molecular Medicine 1
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2tion nor of abnormalities in neurological scoring or behaviour at
least until the age of 12 months (Lappe-Siefke et al, 2003;Wieser
et al, in preparation), indicating that lower Cnp levels can be
fully compensated for.
Nevertheless, decreased CNP expression could have patho-
physiological significance. CNP is among the oligodendrocyte/
myelin-associated genes identified to be most robustly reduced
both on mRNA and protein level in postmortem brains of
schizophrenic, bipolar or major depressive patients (Aston et al,
2005; Mitkus et al, 2008; Tkachev et al, 2003). These findings
suggest that CNP reduction might be critical in a more general
disease process and that the potential role of this molecule is not
restricted to a single diagnostic category but of global relevance
for severe mental disorders.
Several genetic association studies have explored a potential
impact of genetic variability in the CNP gene (chr17q21.2, 11Kb)
on the overall risk for schizophrenia, with inconclusive results
so far (Che et al, 2009; Peirce et al, 2006). Interestingly,
however, a synonymous (Gly/Gly) single nucleotide poly-
morphism (SNP), localized in the fourth exon of the gene
(rs2070106), influences CNP expression in the human cortex,
especially in frontal areas, with the rarer A-allele showing lower
expression in comparison to the G-allele (Iwamoto et al, 2008;
Mitkus et al, 2008; Peirce et al, 2006).
Recent work indicates that in major psychiatric disorders like
schizophrenia and depression, low-grade inflammation con-
stitutes a crucial mechanism in the final common disease
pathway (reviewed in Monji et al, 2009). Already the normal
aging process is associated with slightly increased brain
inflammation characterized by, for example, enhanced levels
of pro-inflammatory cytokines, higher microglial numbers and
increased reactivity with augmented expression of microglial
surface markers (reviewed in, e.g. Miller & Streit, 2007;
Sparkman & Johnson, 2008; Streit, 2006).
To address the pathophysiological relevance of reduced CNP
expression, we chose CNP partial ‘loss-of-function’ genotypes
with aging as an additional ‘pro-inflammatory hit’. We
examined old Cnpþ/ mice and schizophrenic patients with
the AA versus GG genotype in the CNP SNP rs2070106. We
report here the surprising association of CNP partial loss-of-
function with a catatonia-depression syndrome both in mouse
and man upon aging. Importantly, we provide evidence for late-
onset low-grade inflammation in mice as a plausible pathophy-
siological mechanism. In patients carrying the low-expression
genotype (AA), a comparable process might be reflected by
axonal loss in the frontal corpus callosum as detectable by
neuroimaging.RESULTS
Brains of aging CnpR/ mice are characterized by enhanced
inflammation, astrogliosis and axonal degeneration
Immunohistochemical analysis of mouse brains from age 4 to
26 months revealed an age-related increase in the number of
ionized calcium-binding adapter molecule 1 (IBA-1) and Mac-3
positive microglia, infiltrating T-lymphocytes (cluster of 2012 EMBO Molecular Medicinedifferentiation 3; CD3) and astrocytes (glial fibrillary acidic
protein, GFAP) in corpus callosum, striatum and anterior
commissure (month 4 vs. month 26: all p 0.01; for wild-type
(Wt) as well as Cnpþ/ mice). This increase was significantly
more pronounced in old Cnpþ/ as compared to Wt mice
(Fig 1A–H). Axonal swellings (spheroids) as readout of
neurodegenerationwere determined in corpus callosum, striatum
and anterior commissure using amyloid precursor protein (APP)
immunoreactivity (Fig 1I/J). At the age of 4 months, no positive
APP stainingwas detected. Thereafter, an age-dependent increase
in axonal swellings became evident, again more prominent in
Cnpþ/mice (Fig 1I/J). Determination of CnpmRNA expression
in brains of young versus oldmice revealed a remarkable decrease
upon aging in Wt mice, which, however, still maintained levels
above those in Cnpþ/ mice (Fig 1K). In both Wt and Cnpþ/
mice, we found a corresponding age-dependent reduction of
Cnp protein in purified myelin membranes, with the lowest
overall level in aged Cnpþ/ (Fig 1L). Proteolipid protein (Plp), a
control protein for compact myelin, also decreased with age but
independent of the Cnp genotype (Fig 1L). Taken together, old
Cnpþ/mice show a more pronounced low-grade inflammatory
phenotype with axonal degeneration compared to Wt mice.
Aged CnpR/ mice have a slightly elevated anxiety profile
but normal motor activity, coordination and strength
To test whether the pronounced histological changes upon
aging are associated with any behavioural consequences, we
investigated aged (24 months old) Cnpþ/ and Wt mice
employing a comprehensive test battery. In the open field test, a
measure for general locomotor activity and anxiety, Cnpþ/
mice tended to spend less time in the centre than Wt (p¼ 0.096;
Fig 2A). Velocity and total distance travelled in the open field
were comparable in both genotypes (Fig 2B and C), indicating
normal activity. In the elevated plus maze, a classical anxiety
test, open arm visits were reduced in Cnpþ/ mice (p¼ 0.036;
Fig 2D), whereas, the light/dark-box did not yield differences in
the time spent in light (Fig 2E). Freezing behaviour is seen as
another indicator of anxiety/fear in rodents. Cnpþ/ mice
showed higher percentage of freezing in the fear conditioning
chamber already at baseline, that is before measurement of
conditioned or cued memory (p¼ 0.007; Fig 2F), precluding the
use of fear conditioning for memory assessment in these mice.
Like basic motor activity, which proved to be normal, motor
performance, coordination andmotor learning, as evaluated in a
2-day rota-rod testing, were not different between genotypes
(Fig 2G). Also, gait analysis detected no motor abnormalities or
ataxia (see, e.g. Fig 2H depicts forelimb stride of left and right
paw) and muscle strength, measured by the grip strength test,
did not differ between genotypes (Fig 2I). To summarize,
24 months old Cnpþ/ mice show normal overall motor
performance and a mildly elevated anxiety profile in different
anxiety-relevant tests compared to Wt mice.
Aged CnpR/ mice show impaired social and
exploratory behaviour
Social behaviour of aged Wt and Cnpþ/ mice was tested in a
three-partite chamber. This test measures the preference of aEMBO Mol Med 4, 1–12 www.embomolmed.org
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Figure 1. Low-grade brain inflammation and axonal degeneration in aged CnpR/ mice.
A. Representative microscopic images of the corpus callosum from 4 months (upper panels) and 26 months (lower panels) old Wt and Cnpþ/ mice,
immunostained for IBA-1; scale bar 20mm.
B. Bar graph gives the age-dependent quantification of the total number of IBA-1 positive microglia in the corpus callosum of Wt and Cnpþ/ mice. For all
quantifications (B, D, F, H, J), n numbers indicated; mean s.e.m. presented; two-sided Student’s t-test used.
C. Representative microscopic images of the corpus callosum from 4 months (upper panels) and 26 months (lower panels) old Wt and Cnpþ/ mice,
immunostained for Mac-3; scale bar 20mm.
D. Bar graph gives the age-dependent quantification of the total number of Mac-3 positive microglia in the corpus callosum of Wt and Cnpþ/ mice.
E. Representative microscopic images of the corpus callosum from 4 months (upper panels) and 26 months (lower panels) old Wt and Cnpþ/ mice,
immunostained for CD3; black arrows exemplify respective positive cells; scale bar 20mm.
F. Bar graph gives the age-dependent quantification of the total number of CD3 positive T-lymphocytes in the corpus callosum, striatum and anterior
commissure of Wt and Cnpþ/ mice.
G. Representative microscopic images of the corpus callosum from 4 months (upper panels) and 26 months (lower panels) old Wt and Cnpþ/ mice,
immunostained for GFAP; scale bar 20mm.
H. Densitometrical quantification of the GFAP positive area in the corpus callosum.
I. Representative microscopic images of the striatum from 4 months (upper panels) and 26 months (lower panels) old Wt and Cnpþ/mice, immunostained for
APP; black arrows exemplify respective positive cells; scale bar 20mm.
J. Bar graph gives the age-dependent quantification of the APP positive axonal swellings in the corpus callosum, striatum and anterior commissure of Wt and
Cnpþ/ mice.
K. CnpmRNA expression level of Wt and Cnpþ/mice at months 2 and 24, normalized to mean value of ATP synthase subunit beta (Atp5b) and acidic ribosomal
phosphoprotein P0 (Rplp0) as housekeeper genes and to 2 months old Wt (1.0); mean s.e.m. presented; two-sided Student’s t-test used.
L. Cnp protein expression of Wt and Cnpþ/mice at months 2 and 24, compared to Plp as control protein of compact myelin;  low-size band detected in aged
brain myelin with the Plp antibody directed against the C-terminus of PLP/DM20.
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Figure 2. Aged CnpR/ mice show a phenotype composed of catatonia, depression, loss of interest, impaired social interaction and anxiety.
A-C Open arm parameters.
D. Elevated plus maze.
E. Light/dark box paradigm.




J. Sociability testing in the three-partite chamber.
K. Buried-food finding test – latency to find hidden versus visible food pellets.
L. Hole board.
M. Floating rate in a 90 s swim trial.
N. Tail suspension test.
O. Bar test for catatonia.
P. Typical posture of a catatonic Cnpþ/ mouse during the bar test; see also videos of Supporting Information.
Q. Behavioural composite score displayed as intercorrelation network of Z-transformed items. Line thickness indicates the degree of correlation between 2
respective items. The composite score differs between genotypes (p¼ 0.0001). For all behavioural experiments, 24 months old mice were used: Wt n¼ 9–11
and Cnpþ/ n¼ 10–16; mean s.e.m. presented; two-sided or paired t-tests used where applicable.
4mouse for a chamber containing a small wire cage with a
stranger mouse in comparison to a chamber with an empty wire
cage. Aged Wt mice displayed the expected behaviour, that is
spent significantly more time close to the cage with the stranger
mouse compared to the empty wire cage (p¼ 0.019), whereas,
Cnpþ/ mice did not show preference. To control for altered
olfaction as a potential confounder of social behaviour in mice,
the buried-food-finding test was performed, confirming normal
olfactory function in both groups (Fig 2K). In the hole board test,
measuring exploratory behaviour of mice, old Cnpþ/ mice
had significantly less head dips (p¼ 0.011; Fig 2L), indicating
loss of interest (in the absence of any signs of altered basic motor 2012 EMBO Molecular Medicineactivity). To conclude, old Cnpþ/ mice demonstrate several
facets of a loss of interest in the outside world.
Aged CnpR/ mice exhibit features of depression and
catatonia
In the Morris water maze task, Cnpþ/ mice displayed
prominent floating behaviour, precluding analysis of this test
for learning and memory. Analysis of the time mice spent
floating within a swim trial of 90 s yielded threefold higher
floating rates of Cnpþ/ mice in comparison to Wt, which we
interpret as a potential sign of depression (p¼ 0.016; Fig 2M).
To further consolidate this hypothesis, we performed anEMBO Mol Med 4, 1–12 www.embomolmed.org
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suspension test, which determines over 6min the time mice
spend immobile. Fractionated analysis revealed that Cnpþ/
mice had a higher duration of immobility in the second and last
third of the test period compared to Wt (p¼ 0.025; Fig 2N),
consistent with the typical ‘give up’ behaviour of depressed
individuals. A phenotype, thus far observed in mice only upon
induction (e.g. body pinch or drug exposure; Amir, 1986;
Chaperon & Thiebot, 1999) is catatonia/catalepsy, a state of
immobility where mice persist in an externally imposed
abnormal posture for a prolonged time period. Mice are put
into a position where they have to grab a bar while standingwith
their hind paws on the floor (as illustrated in Fig 2P; for a
striking example see videos of Supporting Information). Wt
mice swiftly left this position, whereas, Cnpþ/mice persisted
in this posture (p¼ 0.005; Fig 2O). Taken together, old Cnpþ/
mice exhibit a catatonia-depression syndrome.
Creating a mouse behavioural composite, the ‘catatonia-
depression score’
For translational purposes and confirmation of the internal
consistency of our behavioural readouts in aged mice, we
calculated intercorrelations between the observed behavioural
sub-phenotypes catatonia, depression, loss of interest, impaired
social interaction and anxiety as target variables. These
variables, put together in a composite score, were internally
consistent (Cronbach’s a¼ .686; Fig 2Q). Operationalization of
the score items is detailed in the Materials and Methods Section.
Expectedly, the score was significantly higher in Cnpþ/
(0.32 0.44) than in Wt mice (0.43 0.41; p¼ 0.0001). Based
on these findings, we wondered whether reduced expression of
the CNP gene in aging human patients may have a similar
influence on the phenotype.
Exploiting the GRAS data base for a phenotype-based genetic
association study on the role of CNP genotypes in a
‘catatonia-depression syndrome’
To search for potential behavioural consequences of a
previously described CNP loss-of-function genotype in humans
(Iwamoto et al, 2008; Mitkus et al, 2008; Peirce et al, 2006), we
conducted a phenotype-based genetic association study (PGAS)
targeting the CNP SNP rs2070106 (A/G; Fig 3A) in >1000
schizophrenic patients of the Go¨ttingen Research Association
for Schizophrenia (GRAS) data collection (Begemann et al,
2010; Ribbe et al, 2010). As a first step, we performed a case–
control analysis (schizophrenic patients vs. healthy controls)
and found that this genetic marker does not contribute to an
increased risk of schizophrenia in our population, as proven by
the genotypic and the allelic chi-square comparison (p> 0.05;
Table I of Supporting Information).
Next, a composite score including all variables represented in
the mouse behaviour composite was created that also yielded
good internal consistency with a Cronbach’s a¼ .695 (Fig 3B).
The operationalization of the score items is explained in the
Materials and Methods Section. As illustrated in Fig 3C, the
composite score shows a clear age and genotype (rs2070106)
association: AA subjects develop a significantly higher scorewww.embomolmed.org EMBO Mol Med 4, 1–12with increasing age as compared to GG carriers, with the
dissociation of the regression lines starting at around the age of
40 years. We therefore set a cut-off of 40 years and focused on
the older schizophrenic patients with our further PGAS analysis.
The characteristics of the GRAS patients with an age 40
years, separated by AA versus GG genotype of rs2070106, are
presented in Table 1. These data demonstrate that both
genotype groups are comparable with respect to basic socio-
demographic and clinical/disease control variables but differ
highly significantly in the composite score measuring the
catatonia-depression syndrome. Interestingly, heterozygote
individuals (GA) are very similar to GG subjects. They do not
show an intermediate phenotype in the composite score (Table
II of Supporting Information). Importantly, when screening all
items of the composite separately, a significant age-associated
genotype (GG vs. AA) effect, comparable to the mouse findings,
becomes evident for all (Fig 1 of Supporting Information).
CNP rs2070106 genotypes influence myelin/axon integrity in
the frontal corpus callosum fibres, a candidate region of
catatonia-depression
Based on clinical observation of the affected individuals – both
mouse and man – and the scarce information in the literature on
brain areas potentially involved in the catatonic phenomenon
(Arora & Praharaj, 2007; Northoff et al, 2004), we hypothesized
that aging AA individuals displaying the catatonia-depression
syndrome, in contrast to GG subjects, should show differences
in axonal integrity of frontal crossing fibres. To prove this
hypothesis, a subset of older patients of both genotypes (GG
n¼ 11; AA n¼ 10) from the GRAS sample was selected and
matched according to age, gender and duration of disease
(Table 1). These patients, living all over Germany, were re-
invited to Go¨ttingen for diffusion tensor imaging (DTI). Indeed,
DTI identified higher axial diffusivity (AD) and a higher
apparent diffusion coefficient (ADC) in the frontal part of the
corpus callosum (genu) of AA subjects as compared to GG
patients (p 0.005 for both values; Fig 3E), consistent with a
more progressed axonal loss/degeneration. This effect was
specific for the frontal commissural fibres and was not observed
in the posterior corpus callosum taken as a control region
(Fig 3F). ADC values in the genu were generally correlated with
age but, despite the small number of imaged subjects, resulted in
a significant difference between genotypes upon linear dis-
criminant analysis (LDA; p< 0.05; Fig 3G). Importantly, there
were no global brain volume differences detectable between GG
and AA subjects that could have accounted for DTI results
(p> 0.05 for all comparisons; Fig 3H).DISCUSSION
We report here the unexpected finding that CNP loss-of-function
genotypes are causative of a mental syndrome, consisting of
catatonia, depression, mild anxiety/social withdrawal, impaired
social interaction and reduced interest in the outside world,
which is remarkably similar in mouse and man. In both species,
age becomes an important cofactor, supporting the view that the 2012 EMBO Molecular Medicine 5
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Figure 3. Age- and genotype-dependent association of the CNP rs2070106 SNP with a catatonia-depression syndrome in the GRAS sample of
schizophrenic patients.
A. Schematic view of the human CNP gene structure and location of the synonymous SNP rs2070106 (A/G).
B. Intercorrelation network of all Z-transformed items of the catatonia-depression composite in the GRAS population. Line thickness indicates the degree of
correlation between two respective items.
C. Correlation of genotypes with the catatonia-depression composite score across age groups. Grey bars in the background display the age distribution of the
total GRAS sample of schizophrenic patients (n¼1048). Red or white circles denote mean values of the composite score for the respective age group and
genotype (red, AA; black, GG). Linear regression lines of the genotypes dissociate after the age of 40 years. Pearson product-moment correlation applied.
D. Diffusion tensor imaging (DTI) study selecting the frontal (genu) and caudal (splenium) areas of the corpus callosum as regions of interest.
E,F ADC and AD values plotted according to rs2070106 homozygosity status in genu (E, target region) and splenium (F, control region) of the corpus callosum in a
subgroup of schizophrenic individuals >40 years of age (GG n¼ 11 and AA n¼ 10); results corrected for chlorpromazine equivalents (CPZ). Mean s.e.m.
presented and ANCOVA applied.
G. Correlation of ADC and age in AA and GG genotypes; linear discriminant analysis (LDA) with genotype as grouping variable and ADC and age as independent
variables. Pearson product-moment correlation applied.
H. Magnetic resonance imaging (MRI) volumetric comparison of brain matter, ventricular system and corpus callosum between genotypes. Mean s.e.m.
presented; two-sided Student’s t-test applied.
6underlying mechanism of this mental syndrome is a slowly
progressive neurodegeneration, beginning in subcortical white
matter, as described for the more rapid axonal loss in Cnp null
mutant mice (Edgar et al, 2009; Lappe-Siefke et al, 2003).
Importantly, the CNP loss-of-function genotype is causative of
the here described behavioural syndrome but not of schizo-
phrenia where it may only shape the aging phenotype.
In fact, the human part of this study has been obtained from a
phenotypically extremely well characterized schizophrenic 2012 EMBO Molecular Medicinepopulation (the ‘GRAS data collection’), which was accessible
and where all assessed items of the catatonia-depression
syndrome are potentially relevant for disease subphenotypes.
If a similar database on patients with, for example major
depression had been available, the study would have been
extended to this population. We expect that in individuals
suffering from other mental disorders and even to some
(perhaps mild) degree in healthy subjects, the phenotypical
consequence of the CNP rs2070106 AA genotype will beEMBO Mol Med 4, 1–12 www.embomolmed.org
Research Article
Nora Hagemeyer et al.
Table 1. Sociodemographic variables, composite score (target variable) and clinical/disease control variables of the GRAS sample of schizophrenic patients
40 years with homozygosity in CNP SNP rs2070106 (A/G) and – for comparison – in the subset of patients selected for DTI
GRAS sample 40 years Pb (F/x2) DTI subsample
AA (n¼45) GG (n¼235) AA (n¼10) GG (n¼11)
Sociodemographic variables
Age, years, mean SD (range) 51.047.65 (40.44–69.93) 50.168.42 (44.03–79.49) 0.515 52.074.74 (44.08–60.30) 49.505.34 (40.66–58.71)
Gender, No. (%), male 26 (57.8%) 142 (60.4%) 0.740 7 (70%) 8 (72.7%)
Ethnicity, No. (%), Caucasian 43 (95.6%) 225 (95.7%) 0.892 10 (100%) 11 (100%)
Years of educationa,
mean SD (range)
12.273.82 (0–21) 12.323.36 (0–27) 0.933 12.453.39 (9–19.5) 14.143.16 (8–19)
Target variable
Catatonia-depression composite
score, mean SD (range)
0.380.86 (1.13–1.91) 0.030.74 (1.20–2.44) 0.009
0.006c
0.720.94 (0.99–1.85) 0.020.76 (0.97–0.97)
Clinical/disease control variables
Age at first episode, years,
mean SD (range)
29.7710.18 (15.26–55.61) 30.719.58 (14.73–57.35) 0.533 30.8011.03 (19.35–49.61) 30.8011.03 (22.10–41.89)
Duration of disease (1st episode),
years, mean SD (range)
21.0210.27 (0.16–47.35) 19.3910.86 (0.04–58.23) 0.359 21.2711.26 (0.16–39.13) 19.269.19 (3.30–34.18)
CPZ, mean SD (range) 650.68515.35 (37.5–2295.0) 805.76915.14 (0–7375.0) 0.271 525.93276.29 (175–940) 352.61338.62 (0–1200)
PANSS pos, mean SD (range) 14.006.81 (7–36) 14.556.63 (7–35) 0.619 12.96.01 (7–25) 11.273.66 (7–17)
PANSS neg, mean SD (range) 19.798.48 (7–38) 18.868.21 (7–46) 0.503 21.18.94 (7–35) 17.555.87 (7–27)
PANSS gen, mean SD (range) 35.6614.17 (16–68) 34.6512.54 (16–82) 0.644 35.111.20 (20–55) 29.829.97 (17–51)
PANSS total, mean SD (range) 69.2227.27 (30–128) 68.1024.70 (30–160) 0.795 69.123.64 (37–115) 58.6416.35 (31–90)
GAF, mean SD (range) 42.6820.22 (11–90) 43.8217.56 (10–90) 0.703 43.8014.21 (25–63) 56.5517.41 (35–85)
CGI, mean SD (range) 5.751.35 (3–8) 5.621.13 (2–8) 0.488 6.000.94 (5–7) 5.091.14 (3–7)
CPZ, chlorpromazine equivalents as measure of antipsychotic drug dose; PANSS, positive and negative syndrome scale (consisting of three parts: pos; positive
symptoms; neg, negative symptoms; gen, general psychopathology); GAF, global assessment of functioning; CGI, clinical global impression (see Ribbe et al, 2010
for further details).
Due to missing data upon phenotyping, sample size varies between n¼ 242 and 280 in the sample of individuals with age equal to or above 40 years.
aRating according to graduation/certificate; patients currently in school or in educational training are excluded.
bStatistical methods used: ANOVA or x2-test.
cResult after correction for CPZ.comparable. Along these lines, we show that many schizo-
phrenic patients (and virtually all patients younger than
40 years) lack this syndrome. We would therefore like to stress
again that this syndrome is independent of the diagnosis
schizophrenia, which is also supported by the behavioural
homology of the Cnp mouse model.
Several studies have suggested that schizophrenia and
affective disorders are on a continuum of liability. Genetic
linkage and association studies have proposed common disease
loci for both disorders (Berrettini, 2000; O’Donovan et al, 2008).
Family studies document that first-degree relatives of bipolar
patients have a threefold higher risk for schizophrenia
compared with first-degree relatives of healthy controls (Sham
et al, 1994; Valles et al, 2000). Psychopathological syndromes,
as the catatonia-depression syndrome shown here, shared by
subgroups of both patient populations, would also be
compatible with this overlap. Indeed, catatonia has been found
to be highly prevalent in elderly patients with major depression
(Starkstein et al, 1996). It will be interesting to determine
whether depressed individuals that exhibit catatonic signs are
also preferentially carriers of the CNP rs2070106 AA genotype.
To our knowledge, no spontaneous catalepsy in mice has as
yet been reported, in contrast to pinch- or drug-induced
catalepsy/catatonia (for review see, e.g. Amir, 1986; Chaperon
& Thiebot, 1999). The here observed Cnpþ/ associated
catalepsy/catatonia represents, therefore, the first clearly
defined genetic catatonia model. Catatonia as a prominentwww.embomolmed.org EMBO Mol Med 4, 1–12phenotype has been extensively described by Karl Kahlbaum in
1874 (Kahlbaum, 1874) and entered the Diagnostic and Statistic
Manual of Mental Disorders (APA, 2000) from its first edition in
1952 on, where it appears until now in connection with mood
disorders, schizophrenia, and general medical conditions
(Heckers et al, 2010). Nevertheless, reports on potential brain
areas involved in this phenomenon in man are still scarce and
point to frontal regions, based on, for example pronounced
catatonia in a case with butterfly glioma of the frontal corpus
callosum (Arora and Praharaj, 2007) or on a functional magnetic
resonance imaging (MRI) study in akinetic catatonic patients
during negative emotional stimulation (Northoff et al, 2004).
We hypothesized that genotype-dependent axonal degeneration
should be detectable in the frontal commissural fibres of the
corpus callosum. These considerations were supported by the
fact that the catatonia presented here in the context of a
syndrome is characterized by several features of a primarily
executive control (frontal lobe) deficiency in the absence of any
‘classical’ motor dysfunction. Indeed, we could localize axonal
degeneration, determined by an increased axonal diffusivity in
DTI, selectively to the genu corporis callosi.
The CNP rs2070106 AA genotype leads to reduced expression
of CNP (Mitkus et al, 2008; Peirce et al, 2006), constituting
‘partial loss-of-function’. Since there is an appreciable degree of
linkage disequilibrium across the CNP gene (www.hapmap.
org), the effects seen with the synonymous SNP rs2070106
might well be due to the influence of another genetic variant in 2012 EMBO Molecular Medicine 7
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8close vicinity (e.g. in the 30-untranslated region (30-UTR) of
the CNP gene). Alternatively, according to previous studies,
synonymous SNPs may modify translational timing due to
differential codon usage (Kimchi-Sarfaty et al, 2007) or inactivate
an exonic splicing silencer that compensates for other genetic
variations in exonic splicing enhancers (Nielsen et al, 2007).
We demonstrated increased numbers of inflammatory cells,
gliosis and axonal degeneration in old Cnpþ/mice suggesting
an important role of low-grade inflammation in the described
syndrome. Even though brain sections of human patients with
the respective CNP genotypes were not available in the present
study, the axonal degeneration detected by DTI is an intriguing
observation that might point to the hypothesis of a comparable
disease mechanism in mouse and man. Mechanistic details on
the subcellular functions of CNP in myelinating oligodendro-
cytes have been reported (Gravel et al, 2009) and are under
further investigation. The secondary neuroinflammation is a
well-known cause of nitric oxide-mediated axonal stress and
neurodegeneration (for review see Amor et al, 2010; Smith &
Lassmann, 2002). We note that a diverse group of inherited
myelinopathies in the nervous system of mice can trigger the
recruitment of microglia/macrophages and T-cells (Ip et al,
2006; Kassmann et al, 2007; Martini & Toyka, 2004),
demonstrating that low-grade inflammation is a rather unspe-
cific response of myelinating glial cells to cellular stress,
possibly related to perturbed lipid metabolism (Dumser et al,
2007). Interestingly, low-grade inflammation has been found to
be associated with behavioural consequences in mouse studies
(Bercik et al, 2010) and hypothesized to play a role in mental
diseases (Gardner & Boles, 2011; Monji et al, 2009; Muller &
Schwarz, 2008; Schnieder & Dwork, 2011). Respective first
clinical trials employing antiinflammatory strategies in bipolar
disease and schizophrenia yielded positive signals (Laan et al,
2010; Muller et al, 2010). Having information available on a
predisposing genotype, individualized preventive and thera-
peutic approaches may be possible in the future.
To conclude, the major finding of the present study is the
proof-of-principle that subtle changes of subcortical white
matter can be the cause, rather than merely the consequence, of
a complex neuropsychiatric syndrome. This distinction is
extremely difficult in human patients with a psychiatric disease
of unknown etiology, specifically when pharmacologically
treated and only diagnosed (by MRI) with minor abnormalities
of white matter tracts (Davis et al, 2003). Our analysis was
possible by building on genetic variants of the cell type-specific
CNP gene that lead to a partial loss-of-function genotype in both
mouse and man. Importantly, Cnp heterozygosity (in mice) and
moderately reduced CNP expression levels (in humans) are well
tolerated until an advanced age. At that point, however, haplo-
insufficiency causes a striking phenotype inmice and shapes the
phenotype of a complex psychiatric disease in humans.
Although we have no ultimate proof that moderately reduced
CNP levels in any individual (diseased or healthy) suffice to
trigger a catatonia-depression syndrome upon aging, they
clearly add to other genetic factors (here in patients diagnosed
with schizophrenia) such that the catatonia-depression syn-
drome can be well defined and emerges as remarkably similar to 2012 EMBO Molecular Medicinethe isolated behavioural phenotype of aged Cnp heterozygous
mice. This amazing similarity of the behavioural phenotype
in two different species emphasizes the relevance of glial
dysfunction in psychiatric disorders, and supports the explora-




Blood donors (n¼1045; Begemann et al, 2010) were recruited for the
case-control study. Ethnicity (Caucasian 97.8%; other ethnicities 2%;
unknown 0.2%) was comparable to the patient population (Caucasian
95.5%; other ethnicities 1.8%; unknown 2.7%).
Schizophrenic patients
The GRAS data collection was approved by Ethics Committees of the
Georg-August-University of Go¨ttingen and participating centres, and
comprises at present 1048 patients with Diagnostic and Statistical
Manual of Mental Disorders-IV (DSM-IV; APA, 2000) diagnosis of
schizophrenia (81.7%) or schizoaffective disorder (18.3%), examined
between 2005–2010 in 23 centres all over Germany (for details see
Ribbe et al, 2010). Interviews, testing and ratings were conducted by
an invariable team of trained examiners using the ‘GRAS Manual’
(Begemann et al, 2010; Ribbe et al, 2010).
Catatonia-depression composite
The score consists of five phenotype domains: Depression was
operationalized by items 3 (guilt feelings) and 6 (depression) of
general psychopathology subscale of Positive and Negative Syndrome
Scale (PANSS) (Kay et al, 1987). Catatonia was based on catatonic
signs subscale of the Cambridge Neurological Inventory (gait
mannerism, gegenhalten, mitgehen, imposed posture, abrupt or
exaggerated spontaneous movements, iterative movements, automatic
obedience and echopraxia; Chen et al, 1995). Deficits in social
interaction were built on items 1 (blunted affect) and 3 (poor rapport)
of PANSS negative subscale, combined with item 44 (never feeling
close to another person) of Brief Symptom Inventory (Derogatis &
Melisaratos, 1983). Social withdrawal/anxiety was assessed by item 4
(social withdrawal) of PANSS negative subscale and item 12 (suddenly
scared for no reason) of Brief Symptom Inventory. Loss of interest in the
outside world was estimated by item 7 (self-centred attitude) of PANSS
negative and item 15 (preoccupation) of general subscale. Phenotype
domains were Z-standardized to be normally distributed with
expectation zero and variance one. Higher values indicate worse
outcome. Composite calculation was based on subjects without
missing data (n¼929). Correlations of the five target phenotypes were
assessed using Pearson product–moment correlation and internal
consistency was determined using Cronbach’s a.
Genotyping
Genotyping of SNP rs2070106 was performed using SimpleProbes
(TIB Molbiol, Berlin, Germany) on LightCycler480 (Roche Diagnostics,
Basel, Switzerland).EMBO Mol Med 4, 1–12 www.embomolmed.org
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For MRI/DTI analyses, a subset of patients ‡40 years of both genotypes
(GG n¼11; AA n¼10) from the GRAS sample was selected and
matched according to age, gender and duration of disease. Studies
were conducted at 3T (Tim Trio, Siemens Healthcare, Erlangen,
Germany) using a 32-channel head coil. DTI was performed at
2mm isotropic resolution using diffusion-weighted single-shot
stimulated echo acquisition mode (STEAM) sequences (Hofer et al,
2010; Karaus and Frahm, 2009) combining 6/8 partial Fourier
encoding and parallel imaging. Protocol comprised 24-independent
diffusion gradient directions and b-values of 0 and 900 smm2. A total
of 55 transverse sections (2mm thickness) covered brain parts dorsal
and ventral to the corpus callosum. To increase signal-to-noise ratio,
acquisition was repeated three times (17min). Anatomic images were
based on T1-weighted 3D fast low angle shot (FLASH) MRI sequence
(repetition time TR¼11ms, echo time TE¼4.9ms, flip angle 15-).
DTI regions of interest (ROI)
Before calculation of diffusion tensor, diffusion-weighted MRI data
sets were interpolated to 1mm isotropic resolution and smoothed
with a 3D Gaussian filter (half width 1mm). Individual ROIs were
manually defined on colour-coded maps of the main diffusion
direction without thresholding. ROIs for the corpus callosum were
placed in the midsagittal plane as well as in two directly neighbouring
parasagittal sections covering central portions of genu and most
posterior part of splenium (Hofer & Frahm, 2006). Mean values of
fractional anisotropy (FA), ADC, AD and radial diffusivity (RD) were
calculated.
MRI volumetry
Analyses were performed with an automatic brain segmentation tool
for surface-based cortical thickness (http://surfer.nmr.mgh.harvard.e-
du). T1-weighted images underwent corrections for intensity inhomo-
geneity, skull strip and registration into Talairach space followed by
segmentation into grey matter, white matter and various brain areas.
Regional differences of cortical thickness between patient groups were
investigated using Qdec (FreeSurfer for multiple comparisons and
voxel-based morphometry). Statistics relied on p £0.05 (false discovery
rate corrected for multiple comparisons). Visualization employed an
inflated pial surface model.
Mouse studies
Mouse mutants
Experiments were carried out according to animal policies of the
German Federal State of Niedersachsen. CnpR/ mice were geno-
typed with primers Cnp-E3s, 5(-GCCTTCAAACTGTCCATCTC-3(; Cnp-
E3as, 5(-CCCAGCCCTTTTATTACCAC-3( and puro3, 5(-CATAGCCTGAA-
GAACGAGA-3(.
Immunostaining
Mice were anesthetized with Avertin (Sigma–Aldrich, Taufkirchen,
Germany) and perfused through the left ventricle with 15ml of Hank’s
balanced salt solution (Lonza, Basel, Switzerland), followed by 50ml of
4% paraformaldehyde in phosphate buffered saline (PBS). Brains were
harvested and postfixed in 4% paraformaldehyde overnight at 4-C and
then embedded in Paraplast (Surgipath Paraplast; Leica, Wetzlar,www.embomolmed.org EMBO Mol Med 4, 1–12Germany). Microtome sections of 5mm (Microm HM400, Walldorf,
Germany) were prepared. For diaminobenzidine (DAB)-based immu-
nostaining of paraffin sections, Dako-LSAB2 system or Vectastain Elite
ABC kit (Vector laboratories, Burlingame, CA, USA) were used according
to manufacturer’s instructions. Primary antibodies were directed
against APP (1:750, Chemicon (Millipore) Billerica, MA, USA), CD3
(1:150, Serotec, Oxford, UK), GFAP (1:200, Novocastra (Leica) New-
castle Upon Tyne, UK), IBA-1 (1:1000, Wako, Neuss, Germany) and
Mac-3 (1:400, BD Pharmingen, Franklin Lakes, NJ, USA).
Quantitative real time polymerase chain reaction (qRT-PCR)
qRT-PCR was performed using SYBR green master mix (Applied
Biosystems, Foster City, CA, USA) and 7500 Fast Real-Time PCR System
(Applied Biosystems). Specific qRT-PCR primers were designed by
Roche Universal ProbeLibrary Assay Design Center (Cnp, forward 5(-
TAACCCTCCCTTAGCCCCTG-3(, reverse 5(-GTCCCTAGCATGTGGCAGCT-3(;
for normalization: Atp5b forward 5(-GGATCTGCTGGCCCCATAC-3(,
reverse 5(-CTTTCCAACGCCAGCACCT-3(, Rplp0 forward 5(-GATGCC-
CAGGGAAGACAG-3(, reverse 5(-ACAATGAAGCATTTTGGATAATCA-3().
Data were analysed with Microsoft Excel 2010.
Western blot
Myelin purified from protein lysates was performed according to
(Norton & Poduslo, 1973). For Western blotting, proteins were size-
separated in 12% sodium dodecyl sulphate (SDS)–polyacrylamide gels
(0.2mg/ml), blotted onto polyvinylidene difluoride membranes (Hy-
bond P; GE Healthcare, Mu¨nchen, Germany), blocked with 5% milk
powder in Tris-buffered saline (TBS) and Tris-buffered salineR Triton X-
100 (TBST; 150mM NaCl, 10mM Tris/HCl, pH 7.4; 0.1% Tween20),
and incubated with primary antibodies (CNPase, 1:5000, Sigma, Saint
Louis, MO, USA; Plp (A431), 1:5000; Jung et al, 1996), overnight at 4-C.
Blots were washed with TBS/0.05% Tween20, incubated with
appropriate secondary horseradish peroxidase-conjugated antibodies
(Dianova, Hamburg, Germany), washed with TBS/0.05% Tween20 and
developed by enhanced chemiluminescence (Pierce, Rockford, IL, USA).
Morphometry
Digitized overlapping light microscopic images (20T if not otherwise
stated), fused to a continuous image of a complete corpus callosum
(bregma 0.74mm) by using Photoshop CS5 and ImageJ software were
analysed for absolute numbers of IBA-1 and Mac-3 positive cells. To
quantify GFAP positive areas, a plug-in for the ImageJ software for
semi-automated analysis was implemented (http://www1.em.mpg.de/
wieser). APP positive axonal spheroids (analysed at 40T magnifica-
tion) and CD3 positive T-cells are expressed as total numbers
quantified in corpus callosum, anterior commissure and striatum.
For all stainings, two sections per mouse were quantified.
Behavioural testing
Tests were performed as described in detail previously, using the
following order: Elevated plus maze (Radyushkin et al, 2010), open field
(Radyushkin et al, 2010), light/dark box (Finn et al, 2003), rota-rod
(Radyushkin et al, 2010), gait analysis (Brooks & Dunnett, 2009), grip
strength (Radyushkin et al, 2010), hole board (Radyushkin et al, 2009),
sociability (Moy et al, 2004), buried-food-finding test for olfaction
(Radyushkin et al, 2009), floating behaviour (analysis of swimming/
floating during a 90s trial in the Morris water maze pool; Morris, 1984; 2012 EMBO Molecular Medicine 9
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The paper explained
PROBLEM:
Myelin and white matter abnormalities have been documented
in neuropsychiatric diseases such as schizophrenia, major
depression and bipolar disorder. However, their significance for
disease mechanisms, pathogenesis or phenotypes is still obscure.
A considerable number of postmortem studies found reduced
expression of several myelin genes, including 20,30-cyclic
nucleotide 30-phosphodiesterase (CNP), in the brains of indivi-
duals with severe mental disease. In the present translational
approach, we report for the first time phenotypical consequences
of moderate CNP ‘loss-of-function’ genotypes, that is genetic
variants leading to decreased CNP expression, both inman (single
nucleotide polymorphism rs2070106) and mouse (heterozygous
Cnp null mutant mice).
RESULTS:
We show that reduced CNP expression causes a distinct
behavioural abnormality, seen only upon aging as an additional
‘pro-inflammatory hit’. This phenotype is strikingly similar
between Cnp heterozygous mice and patients with mental
disease, carrying the AA genotype at CNP SNP rs2070106. The
characteristic features in both species are best described as a
‘catatonia-depression’ syndrome and include bizarre posturing,
depression, anxiety, loss of interest in the outside world and
social withdrawal. As a consequence of perturbed CNP expres-
sion, mice show secondary low-grade inflammation and
degeneration of nerve fibres. Analogously, in man, diffusion
tensor imaging points to axonal loss in the frontal corpus
callosum.
IMPACT:
Our genetic data demonstrate that subtle white matter
abnormalities can be the cause of a psychiatric syndrome. To our
knowledge, CNP is the first gene identified to be associated with
catatonia, and aged heterozygous null mutant mice are the first
animal model of spontaneous catatonia. Moderately reduced
CNP expression contributes to a distinct phenotype, which is not
restricted to a single diagnostic category but could explain
features of catatonia-depression in different mental disorders
and possibly – to a milder degree – even in aging healthy
individuals. This knowledge will help defining subgroups of
(aging) subjects who may profit from novel, more specific
therapeutic approaches including anti-inflammatory strategies.
10Stone & Lin, 2011), tail suspension test (Cryan et al, 2005), bar test
(Kuschinsky & Hornykiewicz, 1972; see Fig 2P and videos of Supporting
Information) and fear conditioning (Radyushkin et al, 2009).
Mouse score
For the catatonia-depression score, five phenotype domains were
created: (I) Depression was operationalized by floating time and tail
suspension (delta time of immobility in the last 2min minus first
2min), (II) catatonia by time on bar, (III) deficit in social interaction by
delta time spent with stranger versus empty compartment, (IV) anxiety
by open field-duration in centre, elevated plus maze – open arm visits,
and fear conditioning – freezing at baseline in cue task and (V) loss of
interest by hole board – number of head dips. Composite score
calculation was done in analogy to the human score and based on
mice with not more than two variables missing (n¼27).
Statistical analysis
Statistical analyses were performed using SPSS for Windows version
17.0 (https://www.spss.com/de) and Prism5 (GraphPad Software, San
Diego, CS, USA). Exact procedures are indicated in the respective sections.
Note: All experiments/analyses in both men and mice were performed
by persons unaware of genotypes (‘blinded’).Author contributions
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